Ping Gong

ORCID: 0000-0002-0363-6608
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Synthesis and biological activity
  • Quinazolinone synthesis and applications
  • Cancer therapeutics and mechanisms
  • Synthesis and Characterization of Heterocyclic Compounds
  • Click Chemistry and Applications
  • Synthesis and Biological Evaluation
  • HIV/AIDS drug development and treatment
  • Liver physiology and pathology
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Cancer Mechanisms and Therapy
  • Synthesis and Reactivity of Heterocycles
  • PI3K/AKT/mTOR signaling in cancer
  • Irrigation Practices and Water Management
  • Drug Transport and Resistance Mechanisms
  • Synthesis of heterocyclic compounds
  • Lung Cancer Treatments and Mutations
  • Bioactive Compounds and Antitumor Agents
  • Protein Degradation and Inhibitors
  • Synthesis and Reactions of Organic Compounds
  • Chemical Synthesis and Analysis
  • Plant Physiology and Cultivation Studies
  • Synthetic Organic Chemistry Methods
  • Multicomponent Synthesis of Heterocycles
  • Histone Deacetylase Inhibitors Research

Shenyang Pharmaceutical University
2016-2025

Jilin University
2025

Xinjiang Production and Construction Corps
2017-2024

Shihezi University
2008-2024

Xinjiang Academy of Animal Science
2024

Animal Science Research Institute
2024

Guangzhou University of Chinese Medicine
2024

Changchun University of Science and Technology
2015-2024

Xuzhou Medical College
2024

Institute of Physics
2024

Tumor necrosis factor (TNF)-alpha is a key mediator of sepsis-associated multiorgan failure, including the acute respiratory distress syndrome. We examined role protein tyrosine phosphorylation in TNF-alpha-induced pulmonary vascular permeability. Postconfluent human lung microvascular and artery endothelial cell (EC) monolayers exposed to recombinant TNF-alpha displayed dose- time-dependent increase transendothelial [(14)C]albumin flux absence EC injury. also increased proteins, several...

10.1152/ajplung.00109.2006 article EN AJP Lung Cellular and Molecular Physiology 2006-08-05

Inhibition of the programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) interaction using small-molecule inhibitors is an emerging immunotherapeutic approach. A novel series [1,2,4]triazolo[4,3-a]pyridines were designed and found to be potent PD-1/PD-L1 interaction. Among them, compound A22 exhibited most activity, as assessed by homogenous time-resolved fluorescence assay, with IC50 92.3 nM. Furthermore, dose-dependent elevated interferon-γ production in a co-culture model...

10.1021/acs.jmedchem.9b00312 article EN Journal of Medicinal Chemistry 2019-04-09

A series of novel 1-anilino-4-(arylsulfanylmethyl)phthalazines were designed and synthesized. The structures all the compounds confirmed by IR, 1H-NMR, elemental analysis MS. analogues 1-(3-chloro-4-fluoroanilino)-4-(3,4- difluorophenylthio-methyl)phthalazine (12) 1-(4-fluoro-3-trifluoromethylanilino)-4- (3,4-difluorophenyl-thiomethyl)phthalazine (13) showed higher activity than a cisplatin control when tested in vitro against two different cancer cell lines using microculture tetrazolium...

10.3390/11070574 article EN cc-by Molecules 2006-07-27

Proteolytic processing of amyloid precursor protein (APP) by β- and γ-secretases generates β-amyloid (Aβ) peptides, which accumulate in the brains individuals affected Alzheimer disease. Detergent-resistant membrane microdomains (DRM) rich cholesterol sphingolipid, termed lipid rafts, have been implicated Aβ production. Previously, we others reported that four integral subunits γ-secretase associate with DRM. In this study investigated mechanisms underlying DRM association subunits. We...

10.1074/jbc.m806380200 article EN cc-by Journal of Biological Chemistry 2008-11-22

A series of novel pyrazolo[1,5-a]pyrimidines were designed and synthesized in order to find potent anti-tumor compounds. The structures all the compounds confirmed by IR, (1)H-NMR, elemental analysis, MS. Their activities against cancer cell lines tested MTT method vitro. Compound 19 displayed activity.

10.1002/ardp.200600098 article EN Archiv der Pharmazie 2006-10-12

A series of novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives has been designed and synthesized in order to find anti-tumor compounds. The structures all the compounds were confirmed by IR, 1H-NMR, MS elemental analysis. Their activities against cancer cell lines (HT-1080 Bel-7402) tested MTT method vitro. Among them, compound 19 displayed best activity with IC50 values 12.3 μM 6.1 Bel-7402 HT-1080 respectively.

10.3390/12051136 article EN cc-by Molecules 2007-05-25
Coming Soon ...